Madrigal Pharmaceuticals, Inc. - Common Stock —— 资产负债表 (NASDAQ:MDGL) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 287 M273.33 M362.57 M640.55 M1.04 B1.26 B 负债总额 47.02 M77.22 M165.18 M235.21 M287.86 M656.9 M 权益总额 239.97 M196.11 M197.39 M405.33 M754.38 M602.69 M 负债及股东权益总额 287 M273.33 M362.57 M640.55 M1.04 B1.26 B 总债务 ——49.29 M115.48 M117.57 M339.88 M 净债务 ——49.29 M-518.65 M-813.68 M-643.68 M

新闻

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

Madrigal (MDGL) Reports Q1 Loss, Beats Revenue Estimates

Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for

Madrigal (MDGL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Altimmune Catalysts: 2026 Data Readouts and Financing Risks

ALT Stock: What Pemvidutide Means for MASH, AUD and ALD

Is Altimmune a Buy Before Phase III MASH Starts in 2026?

United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

ALT Pemvidutide Explained: What Makes It Different in MASH